Late Friday, the FDA announced it had postponed for 90 days — and until after the Election — a decision whether to ration the later stage cancer drug Avastin based on cost. With poll numbers that 60 Plus rolled out earlier in the week this is not a shock.

For the first time, an FDA sub-panel used cost as a factor in consideration of drug approval — opening the door to rationing for Avastin and other cutting edge drugs. The American people reject rationing. They do not want doctor’s choices limited by cost — undermining the basic premise of ObamaCare and when drugs are rejected because of their price tag, that is rationing.

Senior citizens, women and breast cancer patients were given a short term reprive. We must ensure that the FDA doesn’t enact it’s own version of a lame duck session in December.

Sixty-three percent (63%) of voters nationwide say guaranteeing that no one is forced to change their health insurance coverage is a higher priority than giving people the choice of a public option. The latest Rasmussen Reports national telephone survey found that just 29% take the opposite view. They say it’s more important to give people the choice between private insurance and a government-sponsored non-profit health insurance option.

Most liberal voters say giving people the choice of a public option is more important. But, most moderates take the opposite view and Republicans overwhelmingly agree with them.